Our clinical studies
We are committed to make our Clinical trials Information and Results accessible and transparent while maintaining participants privacy.
Clinical studies
This site provides information on both ongoing and completed clinical trials sponsored by Pierre Fabre since 2004. Real-world evidence studies which began after 01 January 2020 are also accessible.
Total studies
Current studies
Oncology
Dermatology
Rare diseases
Others
| Title | Therapeutic area | Phase | Status | Start date | (Planned) End date |
|---|---|---|---|---|---|
Phase II trial of oral vinorelbine in combination with capecitabine and trastuzumab as first line therapy in women with previously untreated HER2 positive metastatic breast cancer |
Oncology | Phase II | Completed | March 2004 | 21 May 2019 |
Prospective randomised clinical phase III trial of (alternating IV and oral) vinorelbine plus cisplatin versus docetaxel plus cisplatin in first line chemotherapy of locally advanced or metastatic non... |
Oncology | Phase III | Completed | 02 February 2004 | 01 January 2006 |
Get access to Partner's pivotal studies supporting our authorized drugs in Europe
Results from pivotal studies conducted by our partners and supporting a marketing approval for whom Pierre Fabre is the holder in Europe are shared below: